Innovation on Clinical Application Theory of Cancer Prevention and Treatment Research in the 21st Century: Volume V de Bin Wu

Innovation on Clinical Application Theory of Cancer Prevention and Treatment Research in the 21st Century: Volume V

Bin Wu

Xu Ze

Xu Jie

Whenever one book was finished, both of my eyes were full of tears. It was extremely hard. Every word in these books concreted Dr. Xu Ze's hard work and dedication to oncology and to human health. No one knows how hard it was to finish all this work. Science is endless, and only those who are not afraid of danger or difficult work or risk can reach the science peak. This book is volume 5 in this series of walking out of the new way to conquer cancer. This book summarizes Dr. Xu Ze's thirty items of innovation and explains the detailed concepts about the basis of theories for clinical applications. Dr. Xu Ze has been working in cancer therapy for more than sixty years and works very hard day and night to do the basics and clinical oncology science. The first article is the summary of our research work on cancer prevention and treatment, which has reached the forefront of the world. The second article is a brief description of innovation series of scientific and technology with the research achievements of anti-cancer and anti-cancer metastasis. In brief, no one knows that it was very hard work. Because of the short time, there may be some errors and please forgive us if there is any error. Bin Wu, MD, PhD 02-19-2019 in Timonum

Citește tot Restrânge

Notă biografică

Xu Ze, male, was born in Leping County, Jiangxi Province, on October 1933. He graduated from Tongji Medical University in 1956 and successively held the posts of director of department of surgery of Affiliated Hospital of Hubei College of Traditional Chinese Medicine, professor, chief physician, tutor of postgraduate and doctoral students, president of Experimental Surgery Restitute Institute of Hubei College of Traditional Chinese Medicine, director of Abdominal Tumor Surgery Research Room, and Director of Anti-Carcinomatous Metastasis and Reoccurrence Research Room. In addition, he held concurrent posts of standing director of China Medical Association Wuhan Branch, vice president of Wuhan Micro-Circulation Academy, academic member of International Liver Disease Research, Cooperation and Exchange Center, member of International Surgeon Union, standing member of first, second, third, and fourth editorial board of China Experimental Surgery Journal, standing member of first, second, and third editorial board of Abdominal Surgery Journal. He is enjoying Special Allowance of State Council. He has been engaged in surgery work for forty-nine years and accumulated rich experience in radical operation of lung cancer, esophageal carcinoma, liver cancer, carcinoma of gallbladder, adenocarcinoma of pancreas, gastric carcinoma, and intestinal cancer, as well as in clinical therapy with Chinese traditional medicine combined with Western medicine of prevention of reoccurrence and metastasis after operation. Xu Jie, male, graduated from Hubei College of Traditional Chinese Medicine in 1992. He graduated from the Department of Clinical Medicine in Hubei Medical University in 1996. Now he is chief physician in Hubei University of Traditional Chinese Medicine Hospital and Hubei Provincial Hospital of Surgery. He is engaged in experimental surgical tumor research, general surgery, and urology clinical work. Bin Wu, MD, PhD, graduated from College of Yunyang of Tongji University of Medical Sciences for her MD degree. She studied her master's degree and her PhD in Sun Yat-Sen University of Medical Sciences. After she received her PhD, she worked as a postdoctoral fellow in the John Hopkins Medical School and University of Maryland Medical School. She passed all of her USMLE tests and is going to do her residency training in America. She dedicates herself to oncology clinical and research. Her goal is to conquer cancer, which she believes is great contribution to our health. She has a daughter, Lily Xu.